Skip to content

lettuce aqua extracts effects on brain injury outcome

Assessment of lettuce aqua extracts effects on brain injury outcome in admitted patients in Intensive care unit

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201512105363N7
Enrollment
40
Registered
2016-02-06
Start date
2016-03-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injury. Intracranial injury

Interventions

Intervention 1: lettuce extracts will be administered 250 ml twice daily for 7 days to intervention group. Intervention 2: The control group will receive placebo twice daily for 7 days.
Treatment - Drugs
lettuce extracts will be administered 250 ml twice daily for 7 days to intervention group.
The control group will receive placebo twice daily for 7 days.

Sponsors

Vice- Chancellor for Research of Zanjan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age older than 18 years; Patients with brain injury alone; Admitted in the ICU less than 24 hours; Not receiving immunosuppressive or NSAID; No neurological or psychological diseases; No history of head trauma in the past 4 weeks; Glasgow Coma Scale score Between 5-8; Ability enteral nutrition within 48 hours of admission; The absence of signs of infection or pneumonia; patient's Relatives satisfaction to participate in research exclusion criteria: Patients who die before 48 hours after admission in the ICU; Patients with contraindications to any cause to enteral feeding during the study; Unwillingness of patient's Relatives to participate in research; Any sensitivity to lettuce; Need to take immunosuppressive or NSAID during hospitalization

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Mortality. Timepoint: End of the study. Method of measurement: Records.

Secondary

MeasureTime frame
IL6. Timepoint: first day , 72 h after brain injury. Method of measurement: kit.;CRP. Timepoint: first day , 72 h after brain injury. Method of measurement: kit.;Start time of connecting to the ventilator. Timepoint: The last day of admission in the ICU. Method of measurement: Records.;Connection to ventilator days. Timepoint: The last day of admission in the ICU. Method of measurement: Records.;Length of ICU stay. Timepoint: The last day of admission in the ICU. Method of measurement: Records.;Start time of administration of vasopressor. Timepoint: The last day of admission in the ICU. Method of measurement: Records.;The number of days that the patients need vasopressor. Timepoint: The last day of admission in the ICU. Method of measurement: Records.;GCS at the discharge. Timepoint: The last day of admission in the ICU. Method of measurement: Records.;Ventilator associated pneumonia. Timepoint: Days 3 and 6. Method of measurement: Clinical Pulmonary Infection Score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hamid Khaleghi

Zanjan University of Medical Sciences

H49khaleghi@yahoo.com+98 24 3344 1848

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026